Αρχική Uncategorized Researchers Discover Way to Help Immunotherapy Better Target Solid Tumors Like Breast...

Researchers Discover Way to Help Immunotherapy Better Target Solid Tumors Like Breast Cancer

Immunotherapy is increasingly being used to help fight cancers. It’s been found to be effective against B-cell leukemia or lymphoma. However, it’s been more difficult to use against solid tumors, like breast cancer. New research may be able to change that.

A study published in the Journal of Experimental Medicine says that in mice, solid tumors can be attacked effectively by adding a small molecule to a treatment procedure called chimeric antigen receptor-T cell therapy. This attracts more immune cells into the attack. The findings were from research done by the UNC Lineberger Comprehensive Cancer Center.

PHOTO: ADOBE STOCK/WAVEBREAK 3

Dr. Jonathan Serody is the Elizabeth Thomas Professor of Medicine, Microbiology, and Immunology and director of the Immunology Program at UNC Lineberger. He’s also a co-author of the study. He says these findings could help change things for the better with cancer treatments.

He explains, “We know that CAR T cells are safe for patients with solid tumors but so far they have not been able to cause significant tumor regression in the overwhelming majority of people treated. Now we may have a new approach to make CAR T cells work in solid tumors, which we think could be a game-changer for therapies aimed at an appreciable number of cancers.”

In order to be effective in fighting cancers, T cells need to be able to able to get to the tumor site after infusion. When it comes to non-solid tumors, they can go to bone marrow or other parts of the lymphatic system. This generally doesn’t work for solid tumors. Even if they do find them, the T cells can’t remain there and expand into the tumors due to the surrounding microenvironment.

PHOTO: ADOBE STOCK/MORGAN

To work around this, researchers looked to Th17 and Tc17 cells, which have been found to last longer in that microenvironment. They then combined them with two small molecules that can activate an immune response: stimulator of interferon genes (STING) agonists DMXAA and cGAMP.

DMXAA worked well with mice, but not with humans because it doesn’t activate human STING. However, cGAMP does activate it and is known to boost the human immune system.

In the study, mice injected with cGAMP showed a higher level of T cells, which successfully found the solid tumors. This led to a significant decrease in tumor growth and better chances at survival.

PHOTO: PIXABAY

Serody says they hope they can now study cGAMP in humans, with a goal of first applying it to head and neck cancers. If that goes well, they’d like to expand that to other forms of cancer.

UNC Lineberger currently has nine CAR-T clinical trials open. It’s also working on new trials for treatments of ovarian, head and neck cancers.

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

The American Cancer Society says CAR-T therapy is FDA-approved for some kinds of lymphomas and in some cases of relapsed or hard-to-treat leukemia, but there is hope of treating even more types of cancers as more clinical trials are added.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...